Skip to content

The Therapeutic Effect of BET in COM With ETD

The Therapeutic Effect of Balloon Eustachian Tuboplasty (BET) in Chronic Otitis Media (COM) With Eustachian Tube Dysfunction (ETD)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03440710
Enrollment
60
Registered
2018-02-22
Start date
2018-06-01
Completion date
2019-12-30
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balloon Eustachian Tuboplasty

Brief summary

Currently, surgical treatment of patients with chronic otitis media is one of the most important treatment methods. However, the current results show that some patients with eustachian tube dysfunction can't reconstruct the gas-containing structure of the middle ear after operation. This is a randomized controlled trial that aims to evaluate the therapeutic effect of balloon eustachian tuboplasty (BET) for the treatment in chronic otitis media (COM) with eustachian tube dysfunction (ETD). This future study will aim to address the question: Does BET gain better recovery of auditory function and lower recurrence rate in chronic otitis media with eustachian tube dysfunction?

Interventions

PROCEDUREBET

Balloon Eustachian Tuboplasty

Sponsors

Eye & ENT Hospital of Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who need tympanoplasty, with clear diagnosis of chronic otitis media, middle ear cholesteatoma; 2. Patients with eustachian tube dysfunction using TMM; 3. Subjects or their legal representatives can understand the purpose of the study, show sufficient compliance with the research protocol, and sign the informed consent form.

Exclusion criteria

1. Secondary chronic otitis media (after head and neck cancer radiotherapy); 2. Ipsilateral ear recurrence after surgical treatment, requiring secondary surgery; 3. Two tympanoplasty surgery; 4. Typical allergic rhinitis, nasal endoscopy or imaging studies suggest chronic rhinosinusitis, nasal polyps and other short-term eustachian tube function of a greater impact on the disease; 5. poor general health, with severe liver and kidney dysfunction, coagulation disorders, cardiovascular disease, neurological diseases can not tolerate surgery.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence rate in chronic otitis media with eustachian tube dysfunction6months after the surgeryRecurrence rate in chronic otitis media with eustachian tube dysfunction: with BET vs without BET

Secondary

MeasureTime frameDescription
Hearing change in chronic otitis media with eustachian tube dysfunctionbefore the surgery, and 6months after the surgeryHearing outcome in chronic otitis media with eustachian tube dysfunction: with BET vs without BET
The change of Eustachian tube function using TUBOMANOMETRY (TMM)before the surgery, and 6months after the surgeryEustachian tube function before and after surgery using TUBOMANOMETRY (TMM)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026